The Wistar Institute recently celebrated a ribbon cutting for the opening of its new HIV Cure and Viral Diseases Center. The vision for the center is to ...

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) accepted its supplemental New Drug Application (sNDA) for Yeztugo® (lenacapavir) 300-mg tablet as a ...

Professor Tulio de Oliveira said that a new HIV prevention injection offers six months of protection, while similar long-acting treatments could soon replace daily pills.

Implementation barriers remain largely programmatic, requiring integrated HIV testing, adherence support, STI services, and ...

In the ongoing effort to find new therapeutics for infants born infected with the human immunodeficiency virus, an ...

For decades, HIV has been treated as a lifelong condition. Medicines can control it well, but they rarely eliminate it. Now, a case is shifting that belief. A 63-year-old man has remained free of ...

CAR-T cell therapy is already a potent treatment for certain cancers. Now, a small study is showing early promise for managing HIV. A Miracle cancer therapy that involves engineering a patient’s own ...

Four decades after AIDS first emerged as a global crisis, world leaders, advocates and community representatives gathered at ...

Remarks by Winnie Byanyima, Executive Director of the Joint UN Programme on HIV/AIDS (UNAIDS), at a High-level Meeting in the ...

For millions of people with HIV (PWH), a daily regimen of medications is a lifelong necessity. If they stop taking antiretroviral therapy (ART), the virus usually rushes back within weeks. But this ...